Jun 15, 2026 8:30 am EDT Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing
Jun 8, 2026 8:30 am EDT Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program
May 27, 2026 10:36 am EDT UPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine
May 27, 2026 8:30 am EDT Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine
May 19, 2026 8:30 am EDT Conexeu Sciences Advances 3D Biofabricated Matrix to Move Breast Reconstruction Beyond Implants
May 14, 2026 8:30 am EDT Conexeu Sciences Unveils Defining Commitment: Architecting Bioregeneration(TM)
Nov 20, 2025 9:00 am EST Conexeu Sciences Signals a Major Breakthrough in 'Personalized Human Tissue Creation'
Nov 5, 2025 7:00 am EST Conexeu Sciences Inc. Expands Board of Directors with the Appointments of Dr. Aaron Farberg and Dr. Sebastian Purcell
